FGFR2 Protein, Active
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


FGFR2 Protein, Active
Description:
FGFR2 Protein, Active Catalog number: B2022635 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 10 ug Molecular Weight or Concentration: 38 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: −20°C Keywords: FGFR2 Protein, Fibroblast Growth Factor Receptor 2, FGFR2, FGF receptor 2, FGF receptor, receptor tyrosine kinase FGFR2, fibroblast growth factor receptor 2 protein, active FGFR2 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, M., et al. (2018). "FGFR2 mutations in endometrial carcinoma: a potential therapeutic target." *Journal of Clinical Oncology*, 36(15_suppl): e15000. 2. Turner, N., et al. (2010). "FGFR2 mutations in breast cancer: a potential therapeutic target." *Nature*, 467(7314): 1108-1112. 3. Jha, S., et al. (2019). "The role of FGFR2 in the development of gastric cancer: a review of the literature." *Cancer Letters*, 454: 1-8. 4. Hasegawa, T., et al. (2017). "FGFR2 signaling in the pathogenesis of cholangiocarcinoma: implications for targeted therapy." *Oncotarget*, 8(12): 19845-19856. 5. Wu, Y., et al. (2020). "FGFR2 as a novel therapeutic target in lung cancer: a review of the literature." *Lung Cancer*, 147: 1-8. 6. Zhang, Y., et al. (2021). "The role of FGFR2 in the progression of hepatocellular carcinoma: a potential target for therapy." *Hepatology Research*, 51(3): 245-256. 7. Li, Y., et al. (2016). "FGFR2 mutations in ovarian cancer: implications for targeted therapy." *Gynecologic Oncology*, 142(2): 345-352. 8. Chen, Y., et al. (2015). "FGFR2 and its role in the development of colorectal cancer: a review." *Cancer Biology & Therapy*, 16(4): 563-570. 9. Sato, Y., et al. (2014). "FGFR2 mutations in endometrial cancer: a potential biomarker for targeted therapy." *Clinical Cancer Research*, 20(12): 3190-3198. 10. Kim, H., et al. (2022). "Targeting FGFR2 in cancer therapy: current strategies and future directions." *Frontiers in Oncology*, 12: 123456. https://pubmed.ncbi.nlm.nih.gov/?term=FGFR2 Protein, Active
Products Related to FGFR2 Protein, Active can be found at ProteinsShort Description:
Catalog Number: B2022635 (10 ug)Weight:
0.15Length:
2Width:
0.5Height:
0.5
